Target intelligence / Profile preview

Immunoglobulin lambda joining 5 (IGLJ5)

Target: IGLJ5
Molecular classification: Other (Pseudogene/non-functional gene)

Overview

Immunoglobulin lambda joining 5 (IGLJ5) is a non-protein coding segment within the immunoglobulin lambda locus, classified as non-functional or a pseudogene. It does not encode an active receptor, enzyme, or transporter. There is no evidence for direct involvement in disease mechanisms, drug interactions, or function as a therapeutic target. Potential confusion may arise with "IGLL5," which is an active protein-coding gene in the same locus.

Other names: immunoglobulin lambda joining 5 (non-functional)

Beyond the preview

Go deeper on Immunoglobulin lambda joining 5 (IGLJ5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda joining 5 (IGLJ5).

Explore the full profile